Tuesday, September 22, 2026

IBOVESPA Is 6% Up In The Last 21 Sessions

IBOVESPA Is 6% Up In The Last 21 Sessions

(VIANEWS) - IBOVESPA (BVSP) has been up by 6.36% for the last 21 sessions. At 10:10 EST on Monday, 22 May, IBOVESPA (BVSP) is $110,525.11.

Regarding IBOVESPA's yearly highs and lows, it's 16.02% up from its 52-week low and 8.47% down from its 52-week high.

Volatility

IBOVESPA's last week, last month's, and last quarter's current intraday variation average was 0.39%, 0.31%, and 0.97%, respectively.

IBOVESPA's highest amplitude of average volatility was 0.78% (last week), 0.88% (last month), and 0.97% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IBOVESPA's is considered to be oversold (<=20).

News about

  • According to FXStreet on Monday, 22 May, "Against this backdrop, Wall Street closed with minor losses and the S&P 500 Futures track the same while US Treasury bond yields grind higher."
  • According to FXStreet on Monday, 22 May, "Against this backdrop, S&P 500 Futures appear indecisive while stocks in the Asia-Pacific zone grind lower amid the market's cautious mood ahead of today's key US debt ceiling talks and the week's Aussie-US PMIs, as well as Fed Minutes."
  • According to MarketWatch on Monday, 22 May, "We're developing and delivering connected, digital products that give customers tailored ownership experiences - opening up diverse revenue pools and unprecedented growth for us instead of jockeying for slivers of share with complex hardware in over-served vehicle categories." The stock has edged up 0.2% year to date through Friday, while the S&P 500 has advanced 9.2%."

More news about IBOVESPA (BVSP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com